University of Pennsylvania:企業のM&A・提携動向(医療分野)

◆英語タイトル:University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH67297D
◆発行会社(調査会社):GlobalData
◆発行日:2016年12月13日
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:米国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, criminology, fine arts, finance, operations and information management, telecommunications, theatre arts, and visual studies, among others. Its schools include school of arts and sciences, school of dental medicine, school of design, school of engineering and applied science, school of medicine and school of nursing. The university also offers arts, athletics, healthcare, libraries, online learning and global service facilities. UOP is headquartered in Philadelphia, Pennsylvania, the US.

University of Pennsylvania – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
University of Pennsylvania, Pharmaceuticals & Healthcare, Deal Details 17
Partnerships 17
Tempus Health Enters into Agreement with Penn Medicine 17
Liquid Biotech Enters into Research Agreement with University of Pennsylvania 18
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 19
Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 20
Biogen Enters into Co-Development Agreement with University of Pennsylvania 21
Seres Therapeutics Enters into Agreement with University of Pennsylvania 23
Audentes Therapeutics Enters into Co-Development with University of Pennsylvania 24
Genisphere Enters into Research Agreement with University of Pennsylvania 25
NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 26
Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 27
Janssen Pharma Enters into Agreement with University of Pennsylvania 28
Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 29
Epic Sciences Partners with Abramson Cancer Center 30
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 31
PTC Therapeutics Enters into Agreement with University of Pennsylvania 32
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 33
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 34
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 35
PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 36
Takara Bio Enters Into Research Agreement With University of Pennsylvania 37
Licensing Agreements 38
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 38
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 39
Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 40
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 41
Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 43
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 44
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 46
Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 48
Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 49
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children’s Hospital of Philadelphia 51
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 53
Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 54
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 55
Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 57
Advaxis Amends Its Licensing Agreement With University of Pennsylvania 58
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 59
Equity Offering 60
Tmunity Therapeutics Raises USD10 Million in Equity Financing 60
Asset Transactions 61
University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 61
Acquisition 62
University of Pennsylvania Health System To Acquire Chester County Hospital 62
University of Pennsylvania – Key Competitors 63
Key Employees 64
Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
University of Pennsylvania, Pharmaceuticals & Healthcare, Key Facts 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Tempus Health Enters into Agreement with Penn Medicine 17
Liquid Biotech Enters into Research Agreement with University of Pennsylvania 18
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 19
Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 20
Biogen Enters into Co-Development Agreement with University of Pennsylvania 21
Seres Therapeutics Enters into Agreement with University of Pennsylvania 23
Audentes Therapeutics Enters into Co-Development with University of Pennsylvania 24
Genisphere Enters into Research Agreement with University of Pennsylvania 25
NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 26
Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 27
Janssen Pharma Enters into Agreement with University of Pennsylvania 28
Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 29
Epic Sciences Partners with Abramson Cancer Center 30
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 31
PTC Therapeutics Enters into Agreement with University of Pennsylvania 32
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 33
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 34
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 35
PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 36
Takara Bio Enters Into Research Agreement With University of Pennsylvania 37
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 38
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 39
Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 40
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 41
Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 43
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 44
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 46
Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 48
Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 49
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 51
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 53
Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 54
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 55
Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 57
Advaxis Amends Its Licensing Agreement With University of Pennsylvania 58
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 59
Tmunity Therapeutics Raises USD10 Million in Equity Financing 60
University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 61
University of Pennsylvania Health System To Acquire Chester County Hospital 62
University of Pennsylvania, Key Competitors 63
University of Pennsylvania, Key Employees 64
University of Pennsylvania, Subsidiaries 65

List of Figures
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12

★海外企業調査レポート[University of Pennsylvania:企業のM&A・提携動向(医療分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Consol Energy Inc. (CNX):企業のM&A・提携動向(エネルギー分野)
    Summary CONSOL Energy Inc. (CONSOL Energy) is an integrated energy company. It produces natural gas and coal. The company operates through two primary divisions, namely, natural gas exploration and production (E&P) and coal mining. The E&P division focuses on natural gas and liquids, including produ …
  • Chonbang Co., Ltd. (000950):企業財務及び戦略的SWOT分析
    Summary Chonbang Co., Ltd. (Chonbang), formerly Chonnam Spinning Co.,Ltd is a chemical company that manufactures and markets threads, dyed threads, fabrics and other products. The company offers products which include yarns, fabrics, knit, dyed yarns, embroidery threads and raw materials. It also of …
  • Standard Solar Inc:企業のM&A・提携動向(発電分野)
    Summary Standard Solar Inc (Standard Solar) is a renewable energy company that involves in financing, installing, developing and construction of solar electric systems. SSI provides energy assessment and green energy remodeling services. The company offers solutions that include rooftop, ground moun …
  • Bhoruka Power Corporation Limited:企業のM&A・提携動向(発電分野)
    Summary Bhoruka Power Corporation Limited (BPCL) is a power generation company that installs, operates and maintains mini hydel projects. The company operates hydro stations and wind power plants. Its power projects include Rangenahalli plant, Rayabag plant, Yelisirur plant, Shivapur Plant, Shahapur …
  • Savola Group Company:企業の戦略・SWOT・財務分析
    SummarySavola Group Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • Unipetrol, a.s. (UNIPE):企業のM&A・提携動向(石油・ガス分野)
    Summary Unipetrol, a.s. (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carri …
  • Edelweiss Financial Services Ltd:企業のM&A・事業提携・投資動向
    Edelweiss Financial Services Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Edelweiss Financial Services Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Deutsche Telekom AG (DTE):企業の財務・戦略的SWOT分析
    Deutsche Telekom AG (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AxioMed Spine Corporation:企業のM&A・提携動向(医療機器分野)
    Summary AxioMed Spine Corporation (AxioMed) is a medical device company that develops spinal disc replacement products for patients with degenerative spine disease. AxioMed also develops spinal implants including early artificial disc development efforts. The company’s Freedom lumbar disc is a disc …
  • EnerNOC, Inc. (ENOC):企業のM&A・提携動向(発電分野)
    Summary EnerNOC, Inc. (EnerNOC), formerly EnerNOC, LLC, provides energy intelligence software (EIS) and demand response solutions to enterprises, utilities, and electric power grid operators. The company’s EIS offers enterprise customers with Software-as-a-Service (SaaS) solutions with various areas …
  • Yoshinoya Holdings Co Ltd:企業概要・SWOT・財務分析
    Summary Canadean's "Yoshinoya Holdings Co Ltd : Foodservice - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descriptio …
  • Transpera, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Transpera, Inc. Mergers and Acq …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Zucara Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zucara Therapeutics Inc (Zucara Therapeutics) is a pharmaceutical company that develops novel drug therapies to prevent hypoglycemia in people with diabetes. The company’s technology is used to prevent the dangerous low blood sugar by restoring the body’s ability to counter-regulate hypoglyc …
  • Enterprise Products Partners LP (EPD)-石油・ガス分野:企業M&A・提携分析
    Summary Enterprise Products Partners L.P. (Enterprise Products) is a provider of midstream energy services. The company‘s integrated midstream operations include natural gas gathering, treating, processing, transportation and storage; natural gas liquid transportation, fractionation, storage, and im …
  • Waters Corporation (WAT):医療機器:M&Aディール及び事業提携情報
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • LMI Aerospace, Inc.(防衛):企業概要及びSWOT/財務分析
    Summary Strategic Defence Intelligence's "LMI Aerospace, Inc. : Defence - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busines …
  • Range Resources Corporation:企業のM&A・提携・投資分析
    Range Resources Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Range Resources Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • NEXTracker Inc:電力:M&Aディール及び事業提携情報
    Summary NEXTracker Inc (NEXTracker), a subsidiary of Flex Ltd, is a renewable energy company. The company is engaged in the design, development, and manufacture of single-axis solar trackers for the power plants. It offers services such as design and engineering, project management, installation, pe …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆